Regeneration

SuperReturn Extends Relationship with BackBay Communications

Retrieved on: 
Tuesday, February 13, 2024
Professional Services, Asset Management, Other Communications, Digital Marketing, Data Analytics, Public Relations, Investor Relations, Marketing, Advertising, Communications, Content Marketing, Finance, Consulting, Regeneration, Grimaldi Forum, Investment, News, Growth, Drawdown, PR, Mahim, LP record, GP, Partnership

SuperReturn, the world’s leading private equity and venture capital conference series, has again selected BackBay Communications, an award-winning financial services public relations agency, as its PR and media relations partner for the upcoming SuperReturn International, SuperInvestor, SuperReturn North America and SuperReturn Private Credit US conferences, taking place June 4-7, November 5-8, and November 11-12, in Berlin, Monaco, and New York, respectively.

Key Points: 
  • SuperReturn, the world’s leading private equity and venture capital conference series, has again selected BackBay Communications, an award-winning financial services public relations agency, as its PR and media relations partner for the upcoming SuperReturn International, SuperInvestor, SuperReturn North America and SuperReturn Private Credit US conferences, taking place June 4-7, November 5-8, and November 11-12, in Berlin, Monaco, and New York, respectively.
  • SuperReturn has also engaged BackBay as PR partner for SuperReturn Private Credit Europe on March 11-12 in London.
  • At SuperReturn Private Credit Europe and US, thought leaders will discuss fundraising, credit secondaries, niche and specialty finance, real estate debt and more.
  • For more information on SuperReturn Private Credit Europe, visit https://informaconnect.com/superreturn-private-credit-europe/
    For SuperReturn Private Credit US, visit https://informaconnect.com/superreturn-private-credit/

Global Tissue Engineering Research Analysis Report 2023: Market to Reach $8.9 Billion by 2028, Driven by Rising Funding and Investments and Advancements in Regenerative Medicines - ResearchAndMarkets.com

Retrieved on: 
Thursday, February 8, 2024
Manufacturing, Other Health, Stem Cells, Pharmaceutical, Medical Devices, Hospitals, Genetics, Cardiology, Science, Biotechnology, Other Science, Health, Engineering, Research, Medical Supplies, Government of India, Scaffolding, Investment, Growth, Accident, B cell, Collagen, Trauma, Orthopedic surgery, Regeneration, Biology, Tissue engineering, Inspiration, DST, 3D bioprinting, Market development, USD, Pharmaceutical industry

The global tissue engineering market is projected to reach USD 8.9 billion by 2028 from an estimated USD 4.4 billion in 2023, at a CAGR of 15.3%

Key Points: 
  • The global tissue engineering market is projected to reach USD 8.9 billion by 2028 from an estimated USD 4.4 billion in 2023, at a CAGR of 15.3%
    The growth of this market can be attributed to rising funding and investments for the development of advanced tissue engineering solutions and growing technological advancements in regenerative medicines.
  • The synthetic material segment accounted for the largest share of material in the global tissue engineering market in 2022.
  • The increasing advancements in cell therapies and regenerative medicines are promoting the growth of the tissue engineering market in the region.
  • Market Diversification: Exhaustive information about new products, untapped geographies, recent developments, and investments in the tissue engineering market.

ROSEWOOD MIRAMAR BEACH IS ONE OF FIFTEEN PROPERTIES IN THE WORLD WITH A TRIPLE FIVE-STAR FORBES RATING

Retrieved on: 
Thursday, February 8, 2024
Partnership, Glass, Massage, Travel, Spa, Restaurant, Recognition, City, History, Santa Barbara, California, Regeneration, Sleep, Stainless steel, Michelin, Soil, Hospitality, Forbes Travel Guide, Pacific Ocean, CBD, Farmer, Health, Farm, Bread, F&B, Hotel

MONTECITO, Calif., Feb. 8, 2024 /PRNewswire/ -- Rosewood Miramar Beach, the premier coastal retreat on one of the world's most exclusive coastlines, is pleased to announce that it has been named a Five-Star property with a Five-Star spa, Sense, a Rosewood Spa, and Five-Star restaurant, Caruso's, on the 2024 Forbes Travel Guide Star Rating list. This esteemed accolade celebrates the Resort's commitment to impeccable service, top-tier accommodations, best-in-class amenities and more. The Resort, which opened in Montecito, California in 2019, celebrates its 5-year anniversary March 1st as one of only 15 properties globally and one of only 5 in the U.S. with the coveted triple Five-Star title.

Key Points: 
  • Recognition from Forbes Travel Guide continues to be an industry benchmark and one of the most trusted accolades by consumers.
  • "We are beyond proud of the team and honored to receive the coveted triple Five-Star Forbes rating," said Philipp Posch, Vice President of Hospitality of Caruso.
  • This marks the 4th year Sense, A Rosewood Spa, at Rosewood Miramar Beach receives this coveted award.
  • "We could not be more thrilled to be featured as a triple Five-Star resort on Forbes Travel Guide's prestigious 2024 Star Rating List," said Rick Fidel, Managing Director at Rosewood Miramar Beach.

San Jose Wellness Center, NexGen Health, Elevates Wellness Offerings with the Introduction of BPC 157 Peptide Therapy

Retrieved on: 
Wednesday, February 7, 2024
NexGen, IBD, Inflammation, SAN, Tears, Regenerative medicine, Wound, Regeneration, Wound healing, Inflammatory bowel disease, Patient, Irritable bowel syndrome, BPC, Abrasion, Arthritis, IBS, Health, Pain management, Quality of life, Tropical ulcer, Arthralgia

SAN JOSE, Calif., Feb. 7, 2024 /PRNewswire/ -- NexGen Health, a prominent wellness clinic located in San Jose, California, is pleased to announce the integration of BPC 157 Peptide Therapy into its comprehensive suite of specialized wellness services. This cutting-edge therapy is poised to invigorate the body's innate healing processes, offering renewed hope to individuals seeking optimal health and well-being.

Key Points: 
  • NexGen Health improves patient care by introducing BPC 157 peptide therapy in San Jose, California, empowering healing, and wellness.
  • SAN JOSE, Calif., Feb. 7, 2024 /PRNewswire/ -- NexGen Health, a prominent wellness clinic located in San Jose, California, is pleased to announce the integration of BPC 157 Peptide Therapy into its comprehensive suite of specialized wellness services.
  • "Our commitment to offering BPC 157 Peptide Therapy reflects our passion for providing our patients with the latest advancements in regenerative medicine," says Ilbra Petros, Director of NexGen Health.
  • Our commitment to offering BPC 157 Peptide Therapy reflects our passion for providing our patients with the latest advancements in regenerative medicine," says Ilbra Petros, Director of NexGen Health.

Country Life® Vitamins Unveils Ageless Theory™: A Revolutionary Approach to Healthy Aging

Retrieved on: 
Tuesday, February 6, 2024
Ageless, Multimedia, Lipid, Life, Milk, Advanced glycation end-product, Wind, DNA, Regeneration, Country Life, Ageing, Overalls, Vitamin D, Carnosine, Collection, Marketing, Nutrient, Dicarboxylic acid, AVA, Stem cell, Food, Selenium, Protein, Disease, NSF, Health, Oxidative stress, GFCO, Dietary supplement

HAUPPAUGE, N.Y., Feb. 6, 2024 /PRNewswire-PRWeb/ -- Country Life® Vitamins, a pioneer in nutritional supplements, introduces Ageless Theory™, a groundbreaking line of health supplements representing the latest scientific advances in healthy aging. As demographics shift, with projections indicating that the world's population aged 60 and older will nearly double by 2050(1), Ageless Theory™ emerges as a proactive solution to nourish, support, and renew individuals' whole body health as they age.

Key Points: 
  • "At Country Life, we believe that everyone deserves the benefits of healthy aging.
  • Ageless Theory™ represents the latest scientific advances in healthy aging supplements, with a proven commitment to purity, efficacy, and sustainability.
  • The new line encapsulates the cleanest, most effective, natural ingredients to support healthy aging from within.
  • Sharon Paguio, senior director of marketing for the Country Life brand, says, "At Country Life, we believe that everyone deserves the benefits of healthy aging.

Emyla Tequila Creates Authentic, Ultra Premium Añejo

Retrieved on: 
Tuesday, February 6, 2024
Regeneration, Agave, Ageing, Upland and lowland, Liquor

NEW YORK, Feb. 6, 2024 /PRNewswire/ -- Emyla Añejo Tequila, an ultra premium añejo in one of the fastest-growing tequila categories, is the epitome of luxury in a bottle.

Key Points: 
  • NEW YORK, Feb. 6, 2024 /PRNewswire/ -- Emyla Añejo Tequila, an ultra premium añejo in one of the fastest-growing tequila categories, is the epitome of luxury in a bottle.
  • With nearly 75 years of collective experience in tequila making, the Emyla team, led by founder Art Davtyan, has cultivated top-tier expertise at every production level.
  • Partnering with the acclaimed Casa Maestri distillery, known for its numerous accolades and exceptional production standards, Emyla Tequila epitomizes premium quality.
  • Emyla Añejo Tequila is not just a drink, but an experience.

Generation Lab Emerges from Stealth with Funding Round and Mission to Extend the Human Healthspan – Waitlist for Its Clinically Driven At-Home Aging Test + Personalized Aging Intervention Opens Today

Retrieved on: 
Tuesday, January 30, 2024
Marker beacon, Jools' Annual Hootenanny, Ageing, Inflammation, SAN, Mortality, Genetics, Research, Regeneration, Disease, Conceptual model, Conditional sentence, George Church, University of California, Berkeley, Longevity, QR, Homeostasis, CDC, UC, Harvard Medical School, Risk, Reproduction, University, Health, Generation

The company works with clinicians who can recommend personalized interventions, and Generation Lab can measure the effectiveness of these over time.

Key Points: 
  • The company works with clinicians who can recommend personalized interventions, and Generation Lab can measure the effectiveness of these over time.
  • These diseases are a major cause of morbidity and mortality and place a significant burden on our healthcare system.
  • Moreover, the biological age is quantified by Generation Lab for each function of the body: inflammation, regeneration, homeostasis, reproduction, etc.
  • After subsequent Generation Lab tests, your clinician can review how effective each intervention was and its impact on your health and rate of aging.

Plastics Hall of Fame Announces Class of 2024 Inductees

Retrieved on: 
Thursday, February 1, 2024
University of Hamburg, Polymer, PPI, Dow Chemical Company, Orange County Convention Center, Titanium, Regeneration, University of Connecticut, Plastic, Cellophane, Shin-Etsu Chemical, Chemistry, Nobel Prize, Dow, University of Massachusetts Lowell, Commercialization, Pioneer, University

MINNEAPOLIS, Feb. 1, 2024 /PRNewswire-PRWeb/ -- Seventeen new members will be honored at the Class of 2024 induction ceremony on Sunday, May 5, 2024, in the Orange County Convention Center, Orlando, FL.

Key Points: 
  • Seventeen new Plastic Hall of Fame members will be honored at the Class of 2024 induction ceremony on Sunday, May 5, 2024, in the Orange County Convention Center, Orlando, FL.
  • MINNEAPOLIS, Feb. 1, 2024 /PRNewswire-PRWeb/ -- Seventeen new members will be honored at the Class of 2024 induction ceremony on Sunday, May 5, 2024, in the Orange County Convention Center, Orlando, FL.
  • Established in 1972, the Plastics Hall of Fame has grown to 236 members representing nine countries, which include five Nobel Prize winners in chemistry.
  • The Plastics Hall of Fame recognizes the outstanding achievements of such individuals and inspires those entering the industry around the world.

Dr. Gail K. Naughton, Ph.D., MBA, World Renowned Authority and Pioneer in Regenerative Medicine Named Science Advisor and to Board of Directors of Michal Morrison Inc.

Retrieved on: 
Thursday, February 1, 2024
Regenerative medicine, Cell, Research, Regeneration, Therapy, FDA, Biotechnology, MBA, B cell, Package, Medicine, Tissue engineering, Silver Award, Pharmaceutical industry

βSTEM6 is the result of two decades of research in regenerative medicine and recent advances in stem cell science.

Key Points: 
  • βSTEM6 is the result of two decades of research in regenerative medicine and recent advances in stem cell science.
  • Dr. Naughton, a global leader in regenerative medicine for the past 35 years, has successfully developed significant cell-based therapeutics and bioengineered tissue technologies throughout her career.
  • "I am honored to join the scientists and the board at Michal Morrison Inc.
  • Michal Morrison Inc. has been honored by the beauty industry for its innovative technology and exquisite brand design.

LifeSprout Enters into Licensing Agreement with Boyang Trading to Develop and Commercialize Next-Generation Lumina™ Dermal Filler in Greater China

Retrieved on: 
Wednesday, January 31, 2024
Johns Hopkins University, Regenerative medicine, NLF, Restylane, Regeneration, MD, Clinical trial, Boyang, Biomedicine, Patient, Safety, Plastic, Șaeș, Database, Biomedical engineering, Stand, Associate, Doctor of Philosophy, Common, Johns Hopkins, Pharmaceutical industry

BALTIMORE, Jan. 31, 2024 /PRNewswire/ -- LifeSprout, a privately held regenerative medicine company founded with technology licensed from Johns Hopkins University, today announced it has entered into a definitive agreement with Boyang Trading Co., Ltd. to exclusively develop and commercialize the Lumina™ dermal filler in mainland China, Hong Kong, Macau, and Taiwan.

Key Points: 
  • The technology comprises biomimetic, biocompatible, biodegradable materials engineered to look and feel like native soft tissue.
  • "We are excited to work with the team at Boyang Trading to bring Lumina to patients in Greater China.
  • Their long commercial history in aesthetics and complimentary portfolio of products provide a strong foundation for the launch of our breakthrough platform."
  • LifeSprout is targeting regulatory approvals for Lumina in the United States and European Union in 2025, and concurrently initiating additional clinical trial and registration plans with Boyang Trading for geographies in Greater China.